Showing: 1 - 3 of 3 RESULTS

Trump’s COVID drug was developed using aborted fetal tissue

The antibody cocktail that President Trump received for his COVID-19 infection and touted on Wednesday evening as a “cure” for the deadly virus was developed using cells derived from aborted fetal tissue, a practice the White House and anti-abortion rights groups oppose.



Amanda Banks, Alveda King, Donald Trump standing in front of a crowd holding a sign: Anti-Abortion Activists Demonstrate In D.C. During Annual March For Life


© Mark Wilson / Getty Images
Anti-Abortion Activists Demonstrate In D.C. During Annual March For Life

Last week, Mr. Trump received Regeneron Pharmaceuticals’ cocktail of monoclonal antibodies, an experimental therapeutic for coronavirus that is still undergoing testing and is not FDA approved. In a nearly five-minute video posted to Twitter on Wednesday, the president lauded its effects, calling it “the key.”

“I think this was a blessing from God that I caught [the virus], I think it was a blessing in disguise,” Mr. Trump said in the video. “I caught it, I heard about this drug, I said, ‘Let me take it’ … and it was incredible the way it worked.”

But the way in which the antibody cocktail was developed is at odds with the Trump administration’s position on stem cell research. The drug’s potency was tested in a lab using HEK 293T cells, a cell line originally derived from the kidney tissue of a fetus aborted in the Netherlands in the 1970s, said a spokesperson for Regeneron in an email to CBS News on Thursday. The cells “were used in testing the antibody candidates’ ability to neutralize the virus” and helped researchers “determine the ‘best’ two antibodies, which now make up the REGN-COV2 cocktail,” the spokesperson said.  

Doctor discusses President Trump’s health, treatments, and comments calling therapeutics a cure

UP NEXT

UP NEXT

There is no fetal tissue present in the final product.

Remdesivir, an antiviral drug Mr. Trump received, also was tested using the HEK 293T cells.

Last year, the Trump administration said it would no longer support long-standing funding for medical research by government scientists using human fetal tissue, a move that countered advice from physicians and researchers. The decision was seen as a major victory for anti-abortion rights groups.

Because the fetal cells used in developing Regeneron’s antibody cocktail were originally derived from an abortion prior to the funding ban, a White House official told CBS News on Thursday that the therapeutic wasn’t in violation of the administration’s new policy.

“The Administration’s policy on the use of human fetal tissue from elective abortions in research specifically excluded ‘already-established (as of June 5, 2019) human fetal cell lines,” the official said. “Thus, a product made using extant cell lines that existed before June 5, 2019 would not implicate the Administration’s policy.”

Video: COVID Vaccine Trials Lacking Minority Participants (CBS Sacramento)

COVID Vaccine Trials Lacking Minority Participants

UP NEXT

UP NEXT

Anti-abortion groups, which generally oppose the use of fetal tissue in pharmaceutical research, did not raise issue with the therapeutics used and promoted by the president.

“The president was not given any medicines to treat COVID-19 that involved the destruction of human life,” wrote David Prentice, Ph.D., and Tara Sander

Trump’s “miracle” COVID-19 treatment was developed using cells derived from an aborted fetus: report

Donald Trump
Donald Trump

U.S. President Donald Trump leaves the White House for Walter Reed National Military Medical Center on the South Lawn of the White House on October 2, 2020 in Washington, DC. President Donald Trump and First Lady Melania Trump have both tested positive for coronavirus. Drew Angerer/Getty Images

President Donald Trump has not been shy in his praise for the experimental COVID-19 treatments he received after testing positive last week. In videos posted to Twitter, the president has falsely hailed the therapeutics as “cures” and “miracles coming down from God.”

One of the treatments made available to Trump would have been defeated by his own efforts to thwart the scientific research that made it possible: fetal cell tissue from abortions.

According to Trump’s personal physician, Dr. Sean Conley, the president received a high-dose infusion of monoclonal antibodies last Friday as part of his treatment for COVID-19 infection. Trump was one of the first 10 patients who received the treatment under “compassionate use” emergency access, Salon earlier reported. Several hours after the injection, the president was flown to Walter Reed Medical Center.

The fully-human antibody molecules, made by the pharmaceutical company Regeneron, come from two sources: antibodies identified from humans who have recovered from COVID-19 and the company’s “VelocImmune” mice, which have been genetically modified to have a human immune system, according to a statement provided to Salon by the drug manufacturer.

Related Articles

The lab tests used to evaluate the effectiveness of the antibodies were derived from what the MIT Technology Review pointed out was a standard cell supply known as HEK 293T. It originated as kidney tissue derived from an abortion in the Netherlands in 1973, the same year Roe v. Wade was decided.

Those cells have since been “immortalized” in labs — they keep dividing endlessly, similar to cancerous growth — and have gone through other genetic changes, according to MIT. Over such a length of time, they can become disassociated from their origin.

“It’s how you want to parse it,” a Regeneron spokesperson told MIT. “But the 293T cell lines available today are not considered fetal tissue, and we did not otherwise use fetal tissue.”

But the line connecting the cell lines remains unbroken. The president undeniably benefited medically from cells originating from aborted fetuses.

Regeneron told MIT that other labs also use 293T cells to make what it describes as “pseudoparticles,” or virus-like bodies which have the coronavirus’ “spike” protein. Those particles are necessary in order to test how different antibodies work against the virus. Both antibodies in Regeneron’s treatment would have gone through those tests, MIT reported.

The Trump administration has restricted medical research using fetal tissue from abortions. In 2019, Trump himself overrode top administration scientists, such as Secretary of Health and Human Services (HHS) Alex Azar, and tightened the reins on the National Institutes of Health (NIH) to fund such research. It was an effort pushed by Vice President Mike Pence in an apparent appeal to religious conservative voters.

“This

COVID drug Trump touted as a “cure” was developed using cells derived from aborted fetal tissue

The antibody cocktail that President Trump received for his COVID-19 infection and touted on Wednesday evening as a “cure” for the deadly virus was developed using cells derived from aborted fetal tissue, a practice the White House and anti-abortion rights groups oppose.

Last week, Mr. Trump received Regeneron Pharmaceuticals’ cocktail of monoclonal antibodies, an experimental therapeutic for coronavirus that is still undergoing testing and is not FDA approved. In a nearly five-minute video posted to Twitter on Wednesday, the president lauded its effects, calling it “the key.”

“I think this was a blessing from God that I caught [the virus], I think it was a blessing in disguise,” Mr. Trump said in the video. “I caught it, I heard about this drug, I said, ‘Let me take it’ … and it was incredible the way it worked.”

But the way in which the antibody cocktail was developed is at odds with the Trump administration’s position on stem cell research. The drug’s potency was tested in a lab using HEK 293T cells, a cell line originally derived from the kidney tissue of a fetus aborted in the Netherlands in the 1970s, said a spokesperson for Regeneron in an email to CBS News on Thursday. The cells “were used in testing the antibody candidates’ ability to neutralize the virus” and helped researchers “determine the ‘best’ two antibodies, which now make up the REGN-COV2 cocktail,” the spokesperson said.  

There is no fetal tissue present in the final product.

Remdesivir, an antiviral drug Mr. Trump received, also was tested using the HEK 293T cells.

Last year, the Trump administration said it would no longer support long-standing funding for medical research by government scientists using human fetal tissue, a move that countered advice from physicians and researchers. The decision was seen as a major victory for anti-abortion rights groups.

Because the fetal cells used in developing Regeneron’s antibody cocktail were originally derived from an abortion prior to the funding ban, a White House official told CBS News on Thursday that the therapeutic wasn’t in violation of the administration’s new policy.

“The Administration’s policy on the use of human fetal tissue from elective abortions in research specifically excluded ‘already-established (as of June 5, 2019) human fetal cell lines,” the official said. “Thus, a product made using extant cell lines that existed before June 5, 2019 would not implicate the Administration’s policy.”

Anti-abortion groups, which generally oppose the use of fetal tissue in pharmaceutical research, did not raise issue with the therapeutics used and promoted by the president.

“The president was not given any medicines to treat COVID-19 that involved the destruction of human life,” wrote David Prentice, Ph.D., and Tara Sander Lee, Ph.D., of the Charlotte Lozier Institute, the research arm of the anti-abortion rights political group the Susan B. Anthony List, in a statement emailed to CBS News Wednesday afternoon. “No human embryonic stem cells or human fetal tissue were used to produce the treatments President Trump received – period.”

The researchers did not